Growth financing Okami Medical has recently closed a $45M financing round with new investor Gilde Healthcare and ongoing participation from Vensana Capital and U.S. Venture Partners, signaling strong investor confidence and potential for expanded sales reach, marketing efforts, and expanded product development.

Leadership expansion New leadership appointments include a President and CEO with experience at Inari Medical and a strengthened board with Geoff Pardo and Susana Amorim, indicating a strategic push likely to accelerate commercial scale, channel development, and key account focus.

Key geographies Headquartered in Aliso Viejo, California, with active engagement in U.S. markets, presenting a viable entry to national hospital networks and vascular centers, alongside potential regional partnerships to drive early adoption of embolization solutions.

Clinical focus Product focus on peripheral vascular intervention and novel vascular embolization solutions positions Okami Medical to pursue sales opportunities with interventional radiology, vascular surgery, and cath lab teams seeking innovative devices to address unmet clinical needs.

Funded growth potential Recent substantial financing rounds and board additions imply capital to scale manufacturing, clinical trials, and sales force expansion, enabling targeted outreach to large medical device distributors and hospital systems aligned with vascular care portfolios.